Skip to main content
. 2018 May 17;40(2):243–256. doi: 10.1038/s41401-018-0006-x

Fig. 3.

Fig. 3

Anticancer efficacy in the breast cancer xenograft model. a The photograph of tumors on the last day and tumor growth curves from each group. b The photograph and weigh measurement of the right axillary lymph nodes on the last day from control, DA 50, AX 60, and AX 60 + DA 50 groups. c The BCSC frequency (in the lower right regions) detected through a BD FACSCalibur™ flow cytometer. Data are presented as mean ± SD (n = 5). #P>0.05, nonsignificant; *P<0.05; **P<0.01; ***P<0.001